Just following up on my posts from last week and the week before.
This interview has been published on Nikkei Biotech this morning:
CDI, Inc. "Researching and developing iPS cell-derived T cells for cell therapy targeting cancer"
Unfortunately the article is behind a paywall. I've tried to set up a 2 week free trial but geez... buying a property in Australia is much easier than signing up for that free trial in Japan...
Anyone have access?
Anyways, this seems to fit in perfectly with apceth's findings, Dr Khalid Shah's research, RegCell/FujiFilm investment and our recent patents!
Imagine an announcement that our cells will be used by FujiFilm to target cancer...
Ann: Cynata Files New Patent Application for Cymerus in Oncology, page-14
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.5¢ | 20.0¢ | $13.43K | 65.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 109917 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 9225 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |